These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A basic insight into aptamer-drug conjugates (ApDCs). Xuan W; Peng Y; Deng Z; Peng T; Kuai H; Li Y; He J; Jin C; Liu Y; Wang R; Tan W Biomaterials; 2018 Nov; 182():216-226. PubMed ID: 30138784 [TBL] [Abstract][Full Text] [Related]
4. Enhancing aptamer function and stability via in vitro selection using modified nucleic acids. Meek KN; Rangel AE; Heemstra JM Methods; 2016 Aug; 106():29-36. PubMed ID: 27012179 [TBL] [Abstract][Full Text] [Related]
5. Aptamers: Promising Reagents in Biomedicine Application. Zhou H; Li Y; Wu W Adv Biol (Weinh); 2024 Jun; 8(6):e2300584. PubMed ID: 38488739 [TBL] [Abstract][Full Text] [Related]
6. Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery. Zhou J; Li H; Zhang J; Piotr S; Rossi J J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730942 [TBL] [Abstract][Full Text] [Related]
7. Aptamers as Therapeutics. Nimjee SM; White RR; Becker RC; Sullenger BA Annu Rev Pharmacol Toxicol; 2017 Jan; 57():61-79. PubMed ID: 28061688 [TBL] [Abstract][Full Text] [Related]
8. Cell-specific aptamers for targeted therapies. Cerchia L; Giangrande PH; McNamara JO; de Franciscis V Methods Mol Biol; 2009; 535():59-78. PubMed ID: 19377980 [TBL] [Abstract][Full Text] [Related]
9. Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development. Wang T; Chen C; Larcher LM; Barrero RA; Veedu RN Biotechnol Adv; 2019; 37(1):28-50. PubMed ID: 30408510 [TBL] [Abstract][Full Text] [Related]
10. Aptamers used for biosensors and targeted therapy. Ning Y; Hu J; Lu F Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353 [TBL] [Abstract][Full Text] [Related]
11. High-throughput methods in aptamer discovery and analysis. Cole KH; Lupták A Methods Enzymol; 2019; 621():329-346. PubMed ID: 31128787 [TBL] [Abstract][Full Text] [Related]
12. [Advance in the study of targeting delivery system for siRNA mediated by aptamers]. Wang XL; Wang QQ; Song HF Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847 [TBL] [Abstract][Full Text] [Related]
13. Perspective on the Future Role of Aptamers in Analytical Chemistry. Wu Y; Belmonte I; Sykes KS; Xiao Y; White RJ Anal Chem; 2019 Dec; 91(24):15335-15344. PubMed ID: 31714748 [TBL] [Abstract][Full Text] [Related]
14. Recent developments in cell-SELEX technology for aptamer selection. Kaur H Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2323-2329. PubMed ID: 30059712 [TBL] [Abstract][Full Text] [Related]
15. Tumor-targeted drug delivery with aptamers. Zhang Y; Hong H; Cai W Curr Med Chem; 2011; 18(27):4185-94. PubMed ID: 21838687 [TBL] [Abstract][Full Text] [Related]
17. Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery. Röthlisberger P; Gasse C; Hollenstein M Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29144411 [TBL] [Abstract][Full Text] [Related]
18. Aptamers: selection, modification and application to nervous system diseases. Yang Y; Ren X; Schluesener HJ; Zhang Z Curr Med Chem; 2011; 18(27):4159-68. PubMed ID: 21838689 [TBL] [Abstract][Full Text] [Related]
19. Advances and perspectives in cell-specific aptamers. Sun W; Du L; Li M Curr Pharm Des; 2011; 17(1):80-91. PubMed ID: 21342116 [TBL] [Abstract][Full Text] [Related]
20. The therapeutic potential of cell-internalizing aptamers. Zhou J; Rossi JJ Curr Top Med Chem; 2009; 9(12):1144-57. PubMed ID: 19860714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]